Trans-Splicing RNA Tethering for Efficient Exon Replacement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating human genetic diseases are inadequate in efficiently replacing defective genetic sequences in human cells.

Innovation Solution

A system for trans-splicing using a nucleic acid molecule encoding an exonic sequence and intronic domain, along with an RNA-binding protein, to insert the exonic sequence into a target RNA molecule, without relying on CRISPR-associated proteins, utilizing tethering proteins and engineered small nuclear RNAs to promote efficient insertion and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If CRISPR-associated proteins are used for genetic sequence replacement, then insertion capability is improved, but system complexity and potential off-target effects increase

Engineering Contradiction:
Improveinsertion capabilityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes the CRISPR-associated protein component from the system, replacing it with a simplified trans-splicing mechanism that uses intronic domains and RNA-binding proteins to achieve genetic sequence replacement without the complexity and off-target effects associated with CRISPR systems

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces intronic domains as intermediary elements that mediate the insertion process. These intronic domains contain binding sites for RNA-binding proteins and facilitate the trans-splicing reaction, serving as a bridge between the guide RNA and the target genomic sequence without requiring CRISPR-associated proteins

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If trans-splicing efficiency is increased through multiple components, then productivity is improved, but device complexity increases

Engineering Contradiction:
Improvetrans-splicing efficiencyVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges multiple functional elements into a unified trans-splicing system. The intronic domain integrates guide sequence complementarity, binding sites for RNA-binding proteins, and trans-splicing catalytic elements into a single functional unit that operates efficiently without requiring separate complex components

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent designs the intronic domain to perform multiple functions simultaneously: it provides guide sequence complementarity for target recognition, contains binding sites for RNA-binding proteins to facilitate recruitment, and catalyzes the trans-splicing reaction. This multi-functionality increases efficiency while maintaining system simplicity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260028381A1Systems and methods for promoting trans-splicing
Publication Date: 2026.01.29 TACIT THERAPEUTICS INC
  • US20260028381A1 patent drawing
  • US20260028381A1 patent drawing
  • US20260028381A1 patent drawing

AI summary

Described herein are compositions systems and methods for promoting trans-splicing. In some examples, the system may comprise a nucleic acid molecule. The nucleic acid molecule may encode an exonic sequence. The system may further comprise a tethering fusion protein. The tethering fusion protein may promote an association of the exonic sequence and a target RNA or portion thereof.